eCARTv5 Clinical Deterioration Suite (“eCART”) vs PeraServer and PeraTrend

AgileMD's eCARTv5 is praised for its intuitive interface, seamless EHR integration, and customizable alerts, which streamline workflows and reduce clinical variation. PeraHealth's PeraServer and PeraTrend also offer EHR integration and a visual dashboard, but AgileMD's emphasis on embedded clinical pathways and user-friendly design suggests a potentially superior user experience.

AgileMD's eCARTv5 has demonstrated high accuracy in predicting clinical deterioration, outperforming other early warning scores in retrospective and prospective validation studies across diverse patient populations. It provides early alerts (a median of 5 hours in advance) and guides care with embedded clinical pathways. PeraHealth's Rothman Index also provides real-time predictive analytics and early detection of deterioration, and is validated for neonatal, pediatric, and adult patients. However, the detailed validation results for eCARTv5, including its superior AUROC compared to other established scores, give it a slight edge in demonstrated clinical value.

Both AgileMD and PeraHealth do not publicly disclose their pricing, requiring prospective customers to contact the vendor for a tailored quote. This lack of transparency makes a direct comparison of pricing and value impossible. Both tools are FDA-cleared and HIPAA compliant, suggesting comparable baseline value in terms of regulatory adherence.

AgileMD's eCARTv5 is a cloud-based SaaS solution with seamless EHR integration, designed for rapid deployment (days to weeks) across large health systems. It is SOC-II and HIPAA compliant, with robust security architecture. PeraHealth's offerings also integrate with EHRs and support various deployment methods, including web-based and dedicated kiosk displays. However, AgileMD's explicit mention of rapid, scalable implementation and extensive experience with over 400 hospitals and 4.4 million patient encounters suggests a stronger emphasis on enterprise readiness.

AgileMD's eCARTv5 leverages a gradient-boosted machine-learning algorithm, which has shown superior performance compared to older models like MEWS and NEWS. It continuously assesses up to 97 variables in real-time, offering advanced AI-powered prediction and embedded clinical pathways. While PeraHealth's Rothman Index is also a predictive analytic tool, eCARTv5's specific mention of a gradient-boosted machine learning model and its demonstrated superior performance in recent studies suggest a more innovative approach to clinical deterioration prediction.

Both companies offer essential support and documentation as implied by their FDA clearance and enterprise-level deployments. AgileMD provides documentation, in-person, live online, videos, and webinars for training, along with email and phone support. PeraHealth's FDA documentation mentions software verification and validation testing, and user interfaces like PeraTrend, PeraWatch, and PeraMobile, which inherently require supporting documentation. Without more specific details on the breadth and accessibility of support resources for PeraHealth, it's difficult to definitively declare a winner, resulting in a tie.